It is currently unknown if similar genetic or/and epigenetic abnormalities of ZNF516 also occur in breast cancer, and it is unclear the sequence of the events associated with the aberrant expression of ZNF516 and EGFR. This evidence concerns the gene EGFR and breast cancer.